Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DBE26P
|
|||
| Drug Name |
ADXS-NEO
|
|||
| Drug Type |
Vaccine
|
|||
| Indication | Colon cancer [ICD-11: 2B90.Z] | Phase 1 | [1] | |
| Colorectal cancer [ICD-11: 2B91.Z] | Phase 1 | [2] | ||
| Head and neck cancer [ICD-11: 2D42] | Phase 1 | [1] | ||
| Non-small-cell lung cancer [ICD-11: 2C25.Y; ICD-9: 162] | Phase 1 | [1] | ||
| Company |
Advaxis; Amgen
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 2 | ClinicalTrials.gov (NCT03265080) Expressing Personalized Tumor Antigens Study (NEO). U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.